This page shows the publications co-authored by Ravi Thadhani and David Steele.
Calciphylaxis: risk factors, diagnosis, and treatment. Am J Kidney Dis. 2015 Jul; 66(1):133-46.
Statin use and calcific uremic arteriolopathy: a matched case-control study. Am J Nephrol. 2013; 37(4):325-32.
Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007 Oct; 72(8):1004-13.
Response to the Letter to the Editor by Finsterer and Zarrouk-Mahjoub in Clin Nephrol Case Stud. 2018; 6: 1. Clin Nephrol Case Stud. 2018; 6:2-3.
Hemodialysis failure secondary to hydroxocobalamin exposure. Proc (Bayl Univ Med Cent). 2017 Apr; 30(2):167-168.
Focal segmental glomerulosclerosis associated with mitochondrial disease. Clin Nephrol Case Stud. 2017; 5:20-25.
Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents. Hepatology. 2016 Feb; 63(2):408-17.
Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD. J Am Soc Nephrol. 2012 Sep; 23(9):1551-9.
Metabolite profiling identifies markers of uremia. J Am Soc Nephrol. 2010 Jun; 21(6):1041-1051.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.